Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density

Summary

Bisphosphonates are a type of drug used to prevent and treat bone loss. The purpose of this study is to determine if zoledronate, an investigational bisphosphonate, can improve bone mineral density (BMD) in HIV-infected adults. Study hypothesis: Zoledronate will reduce bone resorption in HIV-infected persons with osteopenia.

Timeline

Start

2005-05

Primary completion

2007-10

Completion

2009-12

Drugs

Indications